ArriVent BioPharma Statistics
Total Valuation
AVBP has a market cap or net worth of $924.99 million. The enterprise value is $642.35 million.
Market Cap | 924.99M |
Enterprise Value | 642.35M |
Important Dates
The last earnings date was Wednesday, November 13, 2024, before market open.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AVBP has 33.70 million shares outstanding. The number of shares has increased by 1,230.98% in one year.
Current Share Class | 33.70M |
Shares Outstanding | 33.70M |
Shares Change (YoY) | +1,230.98% |
Shares Change (QoQ) | +0.24% |
Owned by Insiders (%) | 2.65% |
Owned by Institutions (%) | 47.76% |
Float | 16.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.33 |
P/TBV Ratio | 3.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.28, with a Debt / Equity ratio of 0.00.
Current Ratio | 19.28 |
Quick Ratio | 18.69 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.07% and return on invested capital (ROIC) is -26.05%.
Return on Equity (ROE) | -36.07% |
Return on Assets (ROA) | -24.68% |
Return on Capital (ROIC) | -26.05% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.03M |
Employee Count | 40 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 28.17 |
200-Day Moving Average | 21.98 |
Relative Strength Index (RSI) | 41.86 |
Average Volume (20 Days) | 145,969 |
Short Selling Information
The latest short interest is 3.54 million, so 10.49% of the outstanding shares have been sold short.
Short Interest | 3.54M |
Short Previous Month | 3.41M |
Short % of Shares Out | 10.49% |
Short % of Float | 22.02% |
Short Ratio (days to cover) | 10.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -93.72M |
Pretax Income | n/a |
Net Income | -81.05M |
EBITDA | n/a |
EBIT | -93.72M |
Earnings Per Share (EPS) | -$3.42 |
Balance Sheet
The company has $282.86 million in cash and $213,000 in debt, giving a net cash position of $282.64 million or $8.39 per share.
Cash & Cash Equivalents | 282.86M |
Total Debt | 213,000 |
Net Cash | 282.64M |
Net Cash Per Share | $8.39 |
Equity (Book Value) | 277.49M |
Book Value Per Share | 8.24 |
Working Capital | 277.24M |
Cash Flow
Operating Cash Flow | -68.97M |
Capital Expenditures | n/a |
Free Cash Flow | -68.97M |
FCF Per Share | -$2.05 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AVBP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,230.98% |
Shareholder Yield | -1,230.98% |
Earnings Yield | -8.76% |
FCF Yield | -7.46% |
Analyst Forecast
The average price target for AVBP is $36.80, which is 34.06% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $36.80 |
Price Target Difference | 34.06% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |